U.S. Regulators Order all Imported Heparin Injection Products To be Tested
An alert was issued on March 14, 2008 ordering the detention of all imported supplies of heparin blood-thinner injection products so they could be tested for possible contamination, reported Reuters.
Baxter International Inc recalled most of its U.S. supplies of heparin last month after reports of deaths and serious reactions.
FDA officials have identified a contaminant in some of drug's active ingredient, which comes from a plant in China. They have not determined if the contamination caused the reactions.
If you were harmed after being administered heparin, please complete the form below and a representative of our firm will contact you as soon as possible.
see also:
Heparin Lawsuits
Japanese Firms Recall Heparin as Lawsuits Mount in the United StatesLawsuits Mount as People Come Forward with Heparin Related Injuries
Toxic Heparin
NYT Editorial on Heparin: American Public Vulnerable to Toxic Imports Toxic Heparin due to cost-cutting and sloppy process--lawsuit reviews
Heparin News, 2.28.07
Breaking News: Baxter Recalls Most Heparin Products After 4 DieHeparin Pulled From Market After News of Illness--Free Lawsuit Info


